Regardless, the results presented here demonstrate a signaling pathway encompassing TFAP2C, MILIP, YBX1 and Snai1 that promotes ccRCC metastasis and propose that MILIP may constitute a molecular target for treatment of late-stage ccRCC (Supplementary Fig. 6). This evidence concerns the gene YBX1 and nonpapillary renal cell carcinoma.